Panama City, Republic of Panama [June 29, 2015] — In collaboration with the BC Centre for Excellence in HIV/AIDS (BC-CfE), over a year ago, Panama became the first Central American country to adopt British Columbia’s HIV Treatment as Prevention® (TasP®) strategy. Panama is once again taking a leadership position by announcing the implementation of the UNAIDS 90-90-90 treatment targets to reduce the global HIV/AIDS pandemic by 2030.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
